161 related articles for article (PubMed ID: 8256799)
1. Formation-stimulating regimens other than sodium fluoride.
Riggs BL
Am J Med; 1993 Nov; 95(5A):62S-68S. PubMed ID: 8256799
[TBL] [Abstract][Full Text] [Related]
2. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis.
Augustine M; Horwitz MJ
Curr Osteoporos Rep; 2013 Dec; 11(4):400-6. PubMed ID: 24078470
[TBL] [Abstract][Full Text] [Related]
3. [Anabolic therapy of osteoporosis].
Fernández-García D; Alonso G; Muñoz-Torres M
Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635
[TBL] [Abstract][Full Text] [Related]
4. Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.
Chew CK; Clarke BL
Maturitas; 2017 Mar; 97():53-60. PubMed ID: 28159062
[TBL] [Abstract][Full Text] [Related]
5. New anabolic agents in the treatment of osteoporosis.
Hough S
S Afr Med J; 2003 Oct; 93(10):754-6. PubMed ID: 14652963
[No Abstract] [Full Text] [Related]
6. [Male osteoporosis: current treatments and future options].
Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
[TBL] [Abstract][Full Text] [Related]
7. [Human parathyroid hormone (1-34) as a new therapeutic agent for osteoporosis].
Isogai Y
Clin Calcium; 2005 Jan; 15(1):18-24. PubMed ID: 15632468
[TBL] [Abstract][Full Text] [Related]
8. [Anabolic activity of parathyroid hormone: a new therapeutic perspective in primary osteoporosis].
Fiore CE; Tamburino G
Ann Ital Med Int; 1987; 2(4):321-6. PubMed ID: 3079455
[No Abstract] [Full Text] [Related]
9. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
Marie PJ; Kassem M
Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
[TBL] [Abstract][Full Text] [Related]
10. The role of parathyroid hormone in the management of osteoporosis.
Rosen CJ
Horm Res; 2005; 64 Suppl 2():81-5. PubMed ID: 16286779
[TBL] [Abstract][Full Text] [Related]
11. Anabolic effects of intermittent PTH on osteoblasts.
Greenfield EM
Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
[TBL] [Abstract][Full Text] [Related]
12. Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats.
Yang Y; Aghazadeh-Habashi A; Panahifar A; Wu Y; Bhandari KH; Doschak MR
Drug Deliv Transl Res; 2017 Aug; 7(4):482-496. PubMed ID: 28721611
[TBL] [Abstract][Full Text] [Related]
13. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
[TBL] [Abstract][Full Text] [Related]
14. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis.
Whitfield JF; Morley P
Trends Pharmacol Sci; 1995 Nov; 16(11):382-6. PubMed ID: 8578607
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of old-age osteoporosis].
Münzenberg KJ
Dtsch Med Wochenschr; 1977 Aug; 102(33):1186, 1193-6. PubMed ID: 330133
[No Abstract] [Full Text] [Related]
16. [Anabolic therapy of osteoporosis].
Okopień B; Krysiak R; Labuzek K; Herman ZS
Pol Merkur Lekarski; 2005 Jul; 19(109):118-21. PubMed ID: 16194044
[TBL] [Abstract][Full Text] [Related]
17. New anabolic therapies in osteoporosis.
Rubin MR; Bilezikian JP
Curr Opin Rheumatol; 2002 Jul; 14(4):433-40. PubMed ID: 12118181
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone as an anabolic therapy for women and men.
Bilezikian JP; Rubin MR; Finkelstein JS
J Endocrinol Invest; 2005; 28(8 Suppl):41-9. PubMed ID: 16329201
[TBL] [Abstract][Full Text] [Related]
19. Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
Reeve J; Arlot M; Price TR; Edouard C; Hesp R; Hulme P; Ashby JP; Zanelli JM; Green JR; Tellez M
Eur J Clin Invest; 1987 Oct; 17(5):421-8. PubMed ID: 3121346
[TBL] [Abstract][Full Text] [Related]
20. [Current research in therapy of postmenopausal osteoporosis (author's transl)].
Laroche C; Detilleux M; Sereni D
Sem Hop; 1979 Feb 18-25; 55(7-8):325-9. PubMed ID: 220722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]